Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac Arrhythmia Suppression Trial (CAST)
NCT00000526Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Aug 1986
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of encainide, flecainide, moricizine in ventricular arrhythmia (VA), sponsored by National Heart, Lung, and Blood Institute. Started Aug 1986; status: completed.
02
Drugs
encainideflecainidemoricizine
03
Conditions
ventricular arrhythmia (VA)
Beyond the preview
Go deeper on NCT00000526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000526.